title: CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
abstract: Chemokines have been implicated as key contributors of non-small cell lung cancer (NSCLC) metastasis. However, the role of CXCR7, a recently discovered receptor for CXCL12 ligand, in the pathogenesis of NSCLC is unknown. To define the relative contribution of chemokine receptors to migration and metastasis, we generated human lung A549 and H157 cell lines with stable knockdown of CXCR4, CXCR7, or both. Cancer cells exhibited chemotaxis to CXCL12 that was enhanced under hypoxic conditions, associated with a parallel induction of CXCR4, but not CXCR7. Interestingly, neither knockdown cell line differed in the rate of proliferation, apoptosis, or cell adherence; however, in both cell lines, CXCL12-induced migration was abolished when CXCR4 signaling was abrogated. In contrast, inhibition of CXCR7 signaling did not alter cellular migration to CXCL12. In an in vivo heterotropic xenograft model using A549 cells, expression of CXCR4, but not CXCR7, on cancer cells was necessary for the development of metastases. In addition, cancer cells knocked down for CXCR4 (or both CXCR4 and CXCR7) produced larger and more vascular tumors as compared with wild-type or CXCR7 knockdown tumors, an effect that was attributable to cancer cell-derived CXCR4 out competing endothelial cells for available CXCL12 in the tumor microenvironment. These results indicate that CXCR4, not CXCR7, expression engages CXCL12 to mediate NSCLC metastatic behavior.
  
  
  CONCLUSIONS
  Targeting CXCR4-mediated migration and metastasis may be a viable therapeutic option in NSCLC.
authors.affiliation: Division of Pulmonary and Critical Care, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908. mdb5b@virginia.edu.
authors.forename: Young H
authors.initials: YH
authors.lastname: Choi
authors.forename: Marie D
authors.initials: MD
authors.lastname: Burdick
authors.forename: Brett A
authors.initials: BA
authors.lastname: Strieter
authors.forename: Borna
authors.initials: B
authors.lastname: Mehrad
authors.forename: Robert M
authors.initials: RM
authors.lastname: Strieter
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology*; D002448:Cell Adhesion / Q000235:genetics; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D054371:Chemokine CXCL11 / Q000494:pharmacology; D054377:Chemokine CXCL12 / Q000494:pharmacology*; D002633:Chemotaxis / Q000235:genetics; D042783:Endothelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D051379:Mice; D016513:Mice, SCID; D009362:Neoplasm Metastasis / Q000235:genetics*; D034622:RNA Interference; D034741:RNA, Small Interfering; D054387:Receptors, CXCR / Q000235:genetics; D019718:Receptors, CXCR4 / Q000235:genetics*; D059016:Tumor Microenvironment
chemical_list: C501896:ACKR3 protein, human; C515202:CXCL11 protein, human; C515255:CXCL12 protein, human; C527276:CXCR4 protein, human; D054371:Chemokine CXCL11; D054377:Chemokine CXCL12; D034741:RNA, Small Interfering; D054387:Receptors, CXCR; D019718:Receptors, CXCR4
references.citation: Cancer Res. 2002 Oct 15;62(20):5930-8
references.pmid: 12384559
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11068-73
references.pmid: 20534452
references.citation: Int J Cancer. 2010 Mar 15;126(6):1302-15
references.pmid: 19821487
references.citation: Oncogene. 2010 Aug 12;29(32):4599-610
references.pmid: 20531309
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Cancer Lett. 2008 Sep 28;269(1):46-56
references.pmid: 18502034
references.citation: Int J Cancer. 2010 Dec 1;127(11):2554-68
references.pmid: 20162608
references.citation: Neuron. 2011 Jan 13;69(1):77-90
references.pmid: 21220100
references.citation: Cell. 2008 Feb 8;132(3):463-73
references.pmid: 18267076
references.citation: J Immunol. 2000 Nov 1;165(9):5269-77
references.pmid: 11046061
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: J Exp Med. 2006 Sep 4;203(9):2201-13
references.pmid: 16940167
references.citation: J Immunol. 2001 Oct 15;167(8):4747-57
references.pmid: 11591806
references.citation: J Exp Med. 1996 Sep 1;184(3):981-92
references.pmid: 9064358
references.citation: Br J Cancer. 2002 Apr 22;86(8):1250-6
references.pmid: 11953881
references.citation: Eur J Haematol. 2010 Dec;85(6):472-83
references.pmid: 20887389
references.citation: J Biol Chem. 2005 Jun 10;280(23):22473-81
references.pmid: 15802268
references.citation: J Exp Clin Cancer Res. 2010 Apr 11;29:31
references.pmid: 20380740
references.citation: Cancer Res. 2004 Dec 1;64(23):8604-12
references.pmid: 15574767
references.citation: J Exp Med. 2003 Nov 3;198(9):1391-402
references.pmid: 14597738
references.citation: J Cell Mol Med. 2011 Jun;15(6):1299-309
references.pmid: 21418513
references.citation: Cancer Lett. 2008 Aug 28;267(2):226-44
references.pmid: 18579287
references.citation: Blood. 2006 Mar 1;107(5):1761-7
references.pmid: 16269611
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15735-40
references.pmid: 17898181
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Cancer Res. 2002 Mar 15;62(6):1832-7
references.pmid: 11912162
references.citation: J Am Soc Nephrol. 2009 Aug;20(8):1714-23
references.pmid: 19443644
references.citation: Nature. 1998 Jun 11;393(6685):591-4
references.pmid: 9634237
references.citation: Blood. 2002 Apr 15;99(8):2703-11
references.pmid: 11929756
references.citation: Cancer Metastasis Rev. 2010 Dec;29(4):709-22
references.pmid: 20839032
references.citation: Mol Cancer. 2006 Nov 03;5:56
references.pmid: 17083723
references.citation: J Clin Invest. 1996 Jun 15;97(12):2792-802
references.pmid: 8675690
references.citation: J Oral Pathol Med. 2009 Feb;38(2):214-9
references.pmid: 18624931
references.citation: Cancer Res. 2010 Apr 15;70(8):3299-308
references.pmid: 20388803
references.citation: Cancer Biol Ther. 2008 Nov;7(11):1839-48
references.pmid: 18836306
references.citation: Am J Respir Crit Care Med. 2003 Jun 15;167(12):1676-86
references.pmid: 12626353
references.citation: Folia Histochem Cytobiol. 2010 Jan 1;48(1):104-11
references.pmid: 20529825
references.citation: J Immunol. 1997 Aug 1;159(3):1437-43
references.pmid: 9233641
references.citation: Cancer Res. 2011 May 1;71(9):3268-77
references.pmid: 21398406